With your workforce returning to work in stages, make informed business, health and safety decisions for calculated risk assessment, distancing measures and other workplace rules
A less expensive and quicker alternative to laboratory testing for the initial screening of your workforce
Tests are still performed by your Occupational Nursing team or a qualified clinician to ensure tests are administered correctly
Help employees feel safer returning to work so they know their is a priority by testing for antibodies
You will have powerful data from this first stage of the triage process to understand how to combat viral transmission in your office or worksite.
COVID-19 will impact business for a significant period of time. The sooner you can get your employees back into the workplace safely and with confidence, the better
86% of people want their employer to provide some form of COVID-19 testing
We conducted a survey of 500 employees in the UK (both part- and full-time) between 18th May and 28th May to understand their thoughts on returning to their office or workplace in the near future.
How comfortable are you going back to work?
(1 being not comfortable at all, 10 being 100% comfortable)
1 to 5: 70.2%
6 to 10: 29.8%
Would you go back to the office tomorrow with in-office health and safety measures set in place?
Would you be more comfortable returning to the office, if antibody testing was provided?
Would you like your employer to provide some form of testing?
Testing data can be invaluable for risk assessment, allowing data to help you make informed business decisions
Naturally your workforce will be more comfortable returning to work, if their employer is supporting workplace testing
Testing will assist you in developing measures to control the viral transmission within the workplace, clinics and between employees
Rapid Tests are inexpensive and performed onsite in minutes with results delivered back within 15 minutes
Are These Tests Right For You?
There are different tests currently available on the market for professional use, including PCR Swab testing (testing for active infection) and the Abbotts and Roche laboratory anitbody tests, testing for past infection.
The core differences in our Rapid Test is that this checks for either active infection through the Antigen test or antibodies with the Antibody Test (past infection) with results provided onsite within 15 minutes, without the need of laboratory testing, which can take 2-3 days. This is an inexpensive alternative to start the triage process, gather data to help inform subsequent testing procedures, understand measures that need to be taken in the workplace and adapt rules that you need to be put in place for your employees.
COVID-19, coronavirus, is a viral, infectious diseases that can affect the throat and lungs, causing mild to severe respiratory problems. Symptoms associated with COVID-19 include fever, fatigue and a dry cough. However, many remain asymptomatic and symptoms can take up to 14 days to appear, meaning the virus can easily spread unknowingly to new individuals without antibodies.
When a person is infected with COVID-19, the body responds, activating the immune system and producing immunoglobulins, which attach to the virus to attack and clear the virus away. IgM is the first immunoglobulin produced and is the general antibody that binds with pathogens or viruses. IgM is an indicator of early infection. IgG is a more specialised antibody that specifically binds to the COVID-19 virus and is an indicator of infection in the later stages, usually after 7 days.
The Onsite Rapid Test checks for both antibodies.
Antibodies & Immunity
The Onsite Rapid Test looks for both the IgM and IgG anitbodies within the blood and/or plasma to provide an indication of the presence of antibodies and perhaps immunity. However, it is a misconception that the presence of antibodies is the same as immunity. The science behind immunity is not clear yet, as antibodies do not always have a full lifespan. Scientists around the world are working hard to determine how long antibodies last for, the strength of antibodies in different individuals and communities and how a vaccination can be developed.
To learn more about the clinical trials undertaken for the OnSite Rapid Test, contact us.